Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can Off-the-Shelf CAR T Therapy Prevent Lymphoma Relapse?
Research & Development Can Off-the-Shelf CAR T Therapy Prevent Lymphoma Relapse?

Detecting minimal residual disease through high-sensitivity blood tests allows clinicians to identify high-risk patients who might benefit from immediate cellular therapy despite appearing to be in remission. This shift toward early intervention represents a departure from traditional

Karnataka Launches SAMASTA To Streamline Public Health Data
Management & Regulatory Karnataka Launches SAMASTA To Streamline Public Health Data

Alongside its digital transformation, the Karnataka government is allocating over ten crore rupees to expand mental health services across thirty-one underserved taluks in the Kalyana Karnataka region. This strategic investment forms a core component of the broader SAMASTA initiative, which aims to

Smartwatches Struggle to Track Heart Rate During Swimming
Tech & Innovation Smartwatches Struggle to Track Heart Rate During Swimming

The integration of sophisticated heart rate monitoring into everyday consumer electronics has transformed how individuals manage their personal health and fitness goals across the globe. While the modern smartwatch excels at capturing precise biological data during a morning jog or a high-intensity

Can HEARTS Modernize Mexico’s Cardiovascular Health System?
Management & Regulatory Can HEARTS Modernize Mexico’s Cardiovascular Health System?

Chronic cardiovascular conditions have persisted as the primary cause of mortality across the Mexican landscape, compelling health authorities to overhaul traditional treatment methodologies. Through a strategic alliance with the Pan American Health Organization, the nation has accelerated the

Can AI Identify Pathogens Using Genomic Neighborhoods?
Tech & Innovation Can AI Identify Pathogens Using Genomic Neighborhoods?

The hidden complexity of the bacterial world is finally being unraveled by looking not just at what genes exist within a cell, but precisely where they are located in relation to one another. For decades, the primary method for identifying dangerous microbes involved a simple checklist: if a

Tumor Organoids Help Predict Breast Cancer Drug Response
Research & Development Tumor Organoids Help Predict Breast Cancer Drug Response

The quest to match the right cancer therapy with the right patient has long been hindered by the unpredictable nature of how individual tumors behave within the human body. Researchers at the University of California, San Francisco have recently introduced a transformative approach to oncology by

How Is AI Transforming In Vivo CAR-T Therapy?
Research & Development How Is AI Transforming In Vivo CAR-T Therapy?

The medical world is standing at the precipice of a pharmaceutical revolution that promises to turn the most sophisticated cancer treatments into accessible, off-the-shelf injections. For years, chimeric antigen receptor T-cell therapy has been a beacon of hope for patients with refractory blood

Stem Cell-Derived Heart Valves – Review
Biotech & Bioprocessing Stem Cell-Derived Heart Valves – Review

The physiological toll of valvular heart disease affects nearly 28 million individuals globally, yet the surgical gold standard remains tethered to materials that lack the most fundamental property of life: the ability to grow. Traditional interventions rely heavily on mechanical hardware or fixed

Palmitoyl Tripeptide-1 Modulates Bioengineered Matrix Dynamics
Biotech & Bioprocessing Palmitoyl Tripeptide-1 Modulates Bioengineered Matrix Dynamics

The quest to recreate the intricate complexity of human tissue within a laboratory setting has long been hindered by the limitations of static synthetic materials that fail to communicate with living cells. As bioengineering transitions from simple scaffolds to dynamic, interactive systems,

Is SuperAging Simply the Absence of Alzheimer’s Risk?
Tech & Innovation Is SuperAging Simply the Absence of Alzheimer’s Risk?

The prevailing narrative of human aging has long depicted a slow and inevitable erosion of cognitive faculties, yet a remarkable demographic known as SuperAgers continues to defy these expectations by maintaining memory performance typical of individuals decades younger. These unique individuals,

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later